Literature DB >> 7512032

Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3.

T J Smith1, L A Ducharme, J H Weis.   

Abstract

In this report we demonstrate that murine bone marrow cells cultured in either interleukin (IL)-3 or mast cell growth factor (MGF, also known as c-kit ligand and stem cell factor) differentially express cytokine genes. Bone marrow cells cultured in IL-3 differentiate and proliferate, taking on a mucosal mast cell-like phenotype. These cells express the IL-4 gene. Bone marrow cells cultured in MGF take on a connective tissue mast cell-like phenotype and possess transcripts for both of the subunits of the IL-12 cytokine. Bone marrow cells cultured in both IL-3 and MGF express the IL-4 gene at lower levels than that seen for the IL-3 culture alone, but do not possess IL-12 gene transcripts. The level of IL-12 subunit transcripts derived from the MGF-derived bone marrow cells was compared to that found in splenocytes and activated macrophages, the only cells in which IL-12 production has been previously documented. Both of the IL-12 subunit transcripts were found, compared to a beta-actin control, to be present within MGF-derived cells in the same if not higher quantities than the splenocyte or macrophage cultures. Mucosal mast cells have been previously implicated in the development of the T helper type 2 (TH2) T cell phenotype via their expression of IL-4. The finding that the MGF-derived connective tissue-like mast cells possess IL-12 transcripts suggests that the development of the TH1 T cell pathway may be positively influenced by this type of mast cell.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512032     DOI: 10.1002/eji.1830240408

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

Review 1.  IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses.

Authors:  G Haskó; C Szabó
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 2.  Mast cells in infection and immunity.

Authors:  S N Abraham; R Malaviya
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

Review 3.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

4.  PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeability.

Authors:  Yasuko Furumoto; Nicolas Charles; Ana Olivera; Wai Hang Leung; Sandra Dillahunt; Jennifer L Sargent; Kevin Tinsley; Sandra Odom; Eric Scott; Todd M Wilson; Kamran Ghoreschi; Manfred Kneilling; Mei Chen; David M Lee; Silvia Bolland; Juan Rivera
Journal:  Blood       Date:  2011-09-16       Impact factor: 22.113

Review 5.  Interleukin-12 in infectious diseases.

Authors:  L Romani; P Puccetti; F Bistoni
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

6.  SWAP-70 regulates mast cell FcepsilonRI-mediated signaling and anaphylaxis.

Authors:  Raja R Sivalenka; Manoj Sinha; Rolf Jessberger
Journal:  Eur J Immunol       Date:  2008-03       Impact factor: 5.532

Review 7.  Eosinophils and mast cells in leishmaniasis.

Authors:  Nilda E Rodríguez; Mary E Wilson
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

8.  Induced expression of mRNA for IL-5, IL-6, TNF-alpha, MIP-2 and IFN-gamma in immunologically activated rat peritoneal mast cells: inhibition by dexamethasone and cyclosporin A.

Authors:  C M Williams; J W Coleman
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

9.  Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis.

Authors:  V H Secor; W E Secor; C A Gutekunst; M A Brown
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

10.  Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells.

Authors:  Claudia Gonzalez-Espinosa; Sandra Odom; Ana Olivera; J Peyton Hobson; Maria Eugenia Cid Martinez; Antonio Oliveira-Dos-Santos; Lillian Barra; Sarah Spiegel; Josef M Penninger; Juan Rivera
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.